Results Earnings Call for Q2FY23 of Rossari Biotech
Conference Call with Rossari Biotech Management and Analysts on Q2FY23 Performance and Outlook. Listen to the full earnings transcript.07-11-2022
07-11-2022
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of Earnings Conference call for Q2 & FY2307-11-2022
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Newspaper Publication
News Paper Publication of extracts of Consolidated Un-audited Financial Results for the quarter and half year ended September 30, 2022.07-11-2022
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Rossari Biotech Limited has informed the Exchange regarding a press release dated November 05, 2022, titled "Rossari Biotech announces Q2 & H1 FY23 results"05-11-2022
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Investor Presentation
Q2 & FY23 Earnings Presentation05-11-2022
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Rossari Biotech Limited has informed the Exchange regarding Allotment of 19250 Shares.05-11-2022
Rossari Biotech Ltd - 543213 - Board Meeting Outcome for Outcome Of Board Meeting Held On November 05, 2022
The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022 for the Financial Year 2022-23 and other matters.05-11-2022
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Earnings Conference Call for investors and analysts on Monday, November 07, 2022 at 11:00 A.M. IST02-11-2022
Rossari Biotech Ltd - 543213 - Board Meeting Intimation for Board Meeting Intimation For Approval Of Quarterly Unaudited Financial Results For The Quarter And Half Yearly Ended September 30, 2022
Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2022 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022.28-10-2022
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Acquisition
Rossari Biotech Limited has informed the Exchange that Board of Directors of the Company at their meeting held on October 19, 2022 has approved the incorporation of a wholly owned subsidiary in People's Republic of Bangladesh.19-10-2022